s**u
发帖数: 137 | 1 从名字看显然是个中国人。不容易。
British drugmaker GlaxoSmithKline said Wednesday it has appointed Zhi Hong
to lead a new research unit aimed at the discovery of therapies for
infectious diseases.
Hong, currently executive vice president and chief scientific officer for
San Diego-based Ardea Biosciences, will assume the new position effective
April 23.
In his new role, Hong will oversee discovery operations for treatments for
diseases such as HIV, AIDS and viral hepatitis and for bacterial resistance
to current | i****f
发帖数: 473 | 2 美国的baby boomer一代慢慢都退休了。。。20年以后会有更多中国人顶上的，毕竟美
国人学science phd的太少了，制药/生物这种公司的高层又有一个特定就是多数都有博
士学位。
resistance
【在 s**u 的大作中提到】
: 从名字看显然是个中国人。不容易。
: British drugmaker GlaxoSmithKline said Wednesday it has appointed Zhi Hong
: to lead a new research unit aimed at the discovery of therapies for
: infectious diseases.
: Hong, currently executive vice president and chief scientific officer for
: San Diego-based Ardea Biosciences, will assume the new position effective
: April 23.
: In his new role, Hong will oversee discovery operations for treatments for
: diseases such as HIV, AIDS and viral hepatitis and for bacterial resistance
: to current
| J***2
发帖数: 444 | 3 赶紧viral hepatitis把，中国有1亿以上的患者啊 | s**r
发帖数: 60 | 4 aya... I should focus on R&D section;
not easy for chinese in marketing and strategies.
【在 i****f 的大作中提到】
: 美国的baby boomer一代慢慢都退休了。。。20年以后会有更多中国人顶上的，毕竟美
: 国人学science phd的太少了，制药/生物这种公司的高层又有一个特定就是多数都有博
: 士学位。
:
: resistance
|
|
